Showing results (51-60 of 396) with videos related to

Sort By:
Pageof 40
Leukemia Research|January 1, 1991
Reversible leukaemic regrowth under GM-CSF treatment after chemotherapy for AMLM Koenigsmann, W Hiddemann, T Büchner
Annals of Hematology|December 12, 2003
Mantle cell lymphoma: established therapeutic options and future directionsG Lenz, M Dreyling, W Hiddemann
The Cancer Journal From Scientific American|July 22, 1998
Interferon alfa for the treatment of follicular lymphomasW Hiddemann, F Griesinger, M Unterhalt
Deutsche Medizinische Wochenschrift (1946)|November 15, 2000
[Unclear lactate acidosis in a patient with heart failure under long-term diuretic therapy]T Duell, J Mittermüller, W Hiddemann
Der Internist|February 9, 2007
[Therapy of follicular lymphoma]C Buske, M Unterhalt, W Hiddeman
Der Internist|January 9, 2014
[Chemotherapy of metastatic colorectal cancer]D P Modest, W Hiddemann, V Heinemann
Der Internist|April 1, 2006
[Stem cell therapy. Biology of hematopoietic stem cells]C Buske, H Glimm, M Feuring-Buske
Cell Cycle (Georgetown, Tex.)|November 19, 2005
AML1-ETO needs a partner: new insights into the pathogenesis of t(8;21) leukemiaF Kuchenbauer, M Feuring-Buske, C Buske
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 2000
Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cellsC Binder, M Schulz, W Hiddemann, et al.
Pageof 40